Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix vs Fluzone Immunogenicity and Safety in Children
NCT00383123Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoints: Geometric Mean Titer of Serum Haemagglutination-inhibition (HI) Antibodies, Number of Seroconverted Subjects and 1 more. Started Nov 2006; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00383123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383123.